Patent Review and Derivation Proceedings

ICR 202510-0651-001

OMB: 0651-0069

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2025-10-17
Supplementary Document
2025-07-24
Supplementary Document
2025-07-24
Supplementary Document
2025-07-24
Supplementary Document
2025-07-24
ICR Details
0651-0069 202510-0651-001
Received in OIRA 202507-0651-007
DOC/PTO
Patent Review and Derivation Proceedings
Revision of a currently approved collection   No
Regular 10/17/2025
  Requested Previously Approved
36 Months From Approved 09/30/2028
11,947 11,947
591,930 590,630
76,099,956 76,099,956

The Leahy-Smith America Invents Act, which was enacted into law on September 16, 2011, provided for many changes to the procedures of the Patent Trial and Appeal Board (“PTAB” or “Board,” formerly the Board of Patent Appeals and Interferences) procedures. These changes included the introduction of inter partes review, post-grant review, derivation proceedings, and the transitional program for covered business method patents. Under these administrative trial proceedings, third parties may file a petition with the PTAB challenging the validity of issued patents, with each proceeding having different requirements regarding timing restrictions, grounds for challenging validity, and who may request review. Inter partes review is a trial proceeding conducted at the Board to review the patentability of one or more claims in a patent only on a ground that could be raised under §§ 102 or 103, and only on the basis of prior art consisting of patents or printed publications. Post grant review is a trial proceeding conducted at the Board to review the patentability of one or more claims in a patent on any ground that could be raised under § 282(b)(2) or (3). A derivation proceeding is a trial proceeding conducted at the Board to determine whether (1) an inventor named in an earlier application derived the claimed invention from an inventor named in the petitioner’s application, and (2) the earlier application claiming such invention was filed without authorization. The transitional program for covered business method patents is a trial proceeding conducted at the Board to review the patentability of one or more claims in a covered business method patent. The covered business method program expired on September 16, 2020 and the Board no longer accepts new petitions related to this program, but continues to accept papers in previously-instituted proceedings. This information collection covers information submitted by the public to petition the Board to initiate an inter partes review, post-grant review, derivation proceeding, and the transitional program for covered business method patents, as well as any responses to such petitions, and the filing of any motions, replies, oppositions, and other actions, after a review/proceeding has been instituted.

US Code: 35 USC 6 Name of Law: American Inventor Protection Act
   US Code: 35 USC 134 Name of Law: Leahy-Smith America Invents Act
  
None

0651-AD89 Proposed rulemaking 90 FR 48335 10/17/2025

  90 FR 21757 05/21/2025
90 FR 38958 08/13/2025
No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 11,947 11,947 0 0 0 0
Annual Time Burden (Hours) 591,930 590,630 0 1,300 0 0
Annual Cost Burden (Dollars) 76,099,956 76,099,956 0 0 0 0
Yes
Changing Regulations
No
The Office is proposing new rules of practice before the PTAB to focus inter partes review proceedings on patent claims that have not previously been challenged in litigation or where prior litigation was resolved at an early stage. This proposed rule is intended to promote fairness, efficiency, and predictability in patent disputes.

$34,800,714
No
    Yes
    No
No
No
No
No
Sharon Israel 571 272-9797 sharon.israel@uspto.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/17/2025


© 2025 OMB.report | Privacy Policy